본문 바로가기
KERD
논문KCI 등재

Dual Effect of Hepatic Macrophages on Liver Ischemia and Reperfusion Injury during Liver Transplantation

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Ischemia-reperfusion injury (IRI) is a major complication in liver transplantation (LT) and it is closely related to the recovery of grafts' function. Researches has verified that both innate and adaptive immune system are involved in the development of IRI and Kupffer cell (KC), the resident macrophages in the liver, play a pivotal role both in triggering and sustaining the sterile inflammation. Damage-associated molecular patterns (DAMPs), released by the initial dead cell because of the ischemia insult, firstly activate the KC through pattern recognition receptors (PRRs) such as toll-like receptors. Activated KCs is the dominant players in the IRI as it can secret various pro-inflammatory cytokines to exacerbate the injury and recruit other types of immune cells from the circulation. On the other hand, KCs can also serve in a contrary way to ameliorate IRI by upregulating the anti-inflammatory factors. Moreover, new standpoint has been put forward that KCs and macrophages from the circulation may function in different way to influence the inflammation. Managements towards KCs are expected to be the effective way to improve the IRI.

Abstract

Ischemia-reperfusion injury (IRI) is a major complication in liver transplantation (LT) and it is closely related to the recovery of grafts' function. Researches has verified that both innate and adaptive immune system are involved in the development of IRI and Kupffer cell (KC), the resident macrophages in the liver, play a pivotal role both in triggering and sustaining the sterile inflammation. Damage-associated molecular patterns (DAMPs), released by the initial dead cell because of the ischemia insult, firstly activate the KC through pattern recognition receptors (PRRs) such as toll-like receptors. Activated KCs is the dominant players in the IRI as it can secret various pro-inflammatory cytokines to exacerbate the injury and recruit other types of immune cells from the circulation. On the other hand, KCs can also serve in a contrary way to ameliorate IRI by upregulating the anti-inflammatory factors. Moreover, new standpoint has been put forward that KCs and macrophages from the circulation may function in different way to influence the inflammation. Managements towards KCs are expected to be the effective way to improve the IRI.

참고문헌 (92)

  1. Zarrinpar A, "Liver transplantation: past, present and future", Nat Rev Gastroenterol Hepatol, 10, pp.434~440 (2013)[DOI]
  2. Zhai Y, "Ischaemia-reperfusion injury in liver transplantation--from bench to bedside", Nat Rev Gastroenterol Hepatol, 10, pp.79~89 (2013)[DOI]
  3. Eltzschig HK, "Ischemia and reperfusion--from mechanism to translation", Nat Med, 17, pp.1391~1401 (2011)[DOI]
  4. Zhai Y, "Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation", Am J Transplant, 11, pp.1563~1569 (2011)[DOI]
  5. Dong Z, "The roles of innate immune cells in liver injury and regeneration", Cell Mol Immunol, 4, pp.241~252 (2007)
  6. Lu L, "Innate immune regulations and liver ischemia-reperfusion injury", Transplantation, 100, pp.2601~2610 (2016)[DOI]
  7. Wynn TA, "Macrophage biology in development, homeostasis and disease", Nature, 496, pp.445~455 (2013)[DOI]
  8. Naito M, "Development, differentiation, and maturation of macrophages in the fetal mouse liver", J Leukoc Biol, 48, pp.27~37 (1990)[DOI]
  9. Naito M, "Development, differentiation, and phenotypic heterogeneity of murine tissue macrophages", J Leukoc Biol, 59, pp.133~138 (1996)[DOI]
  10. Davies LC, "Tissue-resident macrophages", Nat Immunol, 14, pp.986~995 (2013)[DOI]
  11. Ikarashi M, "Distinct development and functions of resident and recruited liver Kupffer cells", macrophages, 2013, pp.94, 1325~1336
  12. Tacke F, "Macrophage heterogeneity in liver injury and fibrosis", J Hepatol, 60, pp.1090~1096 (2014)
  13. Dixon LJ, "Kupffer cells in the liver", Compr Physiol, 3, pp.785~797 (2013)
  14. Boltjes A, "The role of Kupffer cells in hepatitis B and hepatitis C virus infections", J Hepatol, 61, pp.660~671 (2014)[DOI]
  15. Sato K, "Pathogenesis of Kupffer cells in cholestatic liver injury", Am J Pathol, 186, pp.2238~2247 (2016)[DOI]
  16. Thaiss CA, "Integration of innate immune signaling", Trends Immunol, 37, pp.84~101 (2016)[DOI]
  17. Chang WJ, "Toll-like receptor signaling in liver ischemia and reperfusion", J Invest Surg, 25, pp.271~277 (2012)[DOI]
  18. Tsung A, "Hepatic ischemia", reperfusion injury involves functional TLR4 signaling in nonparenchymal cells, 2005, pp.175, 7661~7668
  19. Hui W, "Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia", reperfusion injury, 2009, pp.389, 328~332
  20. Nace GW, "Cellular-specific role of toll-like receptor 4 in hepatic ischemia-reperfusion injury in mice", Hepatology, 58, pp.374~387 (2013)[DOI]
  21. Tsung A, "The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion", J Exp Med, 201, pp.1135~1143 (2005)[DOI]
  22. Tsung A, "HMGB1 release induced by liver ischemia involves toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling", J Exp Med, 204, pp.2913~2923 (2007)[DOI]
  23. Zhang W, "Isoglycyrrhizinate magnesium enhances hepatoprotective effect of FK506 on ischemia-reperfusion injury through HMGB1 inhibition in a rat model of liver transplantation", Transplantation, 101, pp.2862~2872 (2017)[DOI]
  24. Huang H, "Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia", reperfusion: a role for intracellular high-mobility group box 1 in cellular protection, 2014, pp.59, 1984~1997
  25. Zhao G, "Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury", Sci Rep, 7, pp.46272~ (2017)[DOI]
  26. Huang H, "Endogenous histones function as alarmins in sterile inflammatory liver injury through toll-like receptor 9 in mice", Hepatology, 54, pp.999~1008 (2011)[DOI]
  27. Kariko K, "mRNA is an endogenous ligand for toll-like receptor 3", J Biol Chem, 279, pp.12542~12550 (2004)[DOI]
  28. Cavassani KA, "TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events", J Exp Med, 205, pp.2609~2621 (2008)[DOI]
  29. Calderwood SK, "Extracellular HSPs: the complicated roles of extracellular HSPs in immunity", Front Immunol, 7, pp.159~ (2016)
  30. Nomura J, "Intracellular ATP decrease mediates NLRP3 inflammasome activation upon nigericin and crystal stimulation", J Immunol, 195, pp.5718~5724 (2015)[DOI]
  31. Baron L, "The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine", Cell Death Dis, 6, pp.e1629~ (2015)[DOI]
  32. Szabo G, "Inflammasome activation and function in liver disease", Nat Rev Gastroenterol Hepatol, 12, pp.387~400 (2015)[DOI]
  33. Su GL, "Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation", Am J Physiol Gastrointest Liver Physiol, 283, pp.G256~G265 (2002)[DOI]
  34. Zhai Y, "Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury", Transplantation, 85, pp.1016~1022 (2008)[DOI]
  35. Schwabe RF, "TNF-<TEX>${\alpha}$<", TEX>-induced liver injury: role of IKK, JNK, and ROS pathways, 2006, pp.290, G583~G589
  36. Li J, "Tumour necrosis factor-<TEX>${\alpha}$<", TEX> promotes liver ischaemia-reperfusion injury through the PGC-<TEX>$1{\alpha}$<, Mfn2 pathway, pp.J Cell Mol Med, 2014[DOI]
  37. Abu-Amara M, "Liver ischemia", reperfusion injury: processes in inflammatory networks--a review, 2010, pp.16, 1016~1032
  38. Peralta C, "Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu", J Hepatol, 59, pp.1094~1106 (2013)[DOI]
  39. Brock RW, "Initiation of remote hepatic injury in the rat: interactions between Kupffer cells, tumor necrosis factor-<TEX>${\alpha}$<", TEX>, and microvascular perfusion, 1999, pp.30, 137~142
  40. Suyavaran A, "TNF-<TEX>${\alpha}$<", TEX> suppression by glutathione preconditioning attenuates hepatic ischemia reperfusion injury in young and aged rats, 2015, pp.64, 71~81
  41. Hernandez-Alejandro R, "Reduction of liver ischemia reperfusion injury by silencing of TNF-<TEX>${\alpha}$<", TEX> gene with shRNA, 2012, pp.176, 614~620
  42. Feng M, "Tumor necrosis factor-<TEX>${\alpha}$<", TEX> preconditioning attenuates liver ischemia, endoplasmic reticulum calcium-ATPase function, pp.J Surg Res, 2013[DOI]
  43. Teoh N, "Dual role of tumor necrosis factor-<TEX>${\alpha}$<", TEX> in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-<TEX>${\alpha}$<, Hepatology, pp.2004, 39[DOI]
  44. Strowig T, "Inflammasomes in health and disease", Nature, 481, pp.278~286 (2012)[DOI]
  45. Davis BK, "The inflammasome NLRs in immunity, inflammation, and associated diseases", Annu Rev Immunol, 29, pp.707~735 (2011)[DOI]
  46. Huang H, "Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury", J Immunol, 191, pp.2665~2679 (2013)[DOI]
  47. Kamo N, "ASC", caspase-1, TEX> signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia, pp.reperfusion injury, Hepatology[DOI]
  48. Kim HY, "Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia", reperfusion, 2015, pp.282, 259~270
  49. Li JY, "GdCl3 abates hepatic ischemia-reperfusion injury by inhibiting apoptosis in rats", Hepatobiliary Pancreat Dis Int, 8, pp.518~523 (2009)
  50. Tomiyama K, "Inhibition of Kupffer cell-mediated early proinflammatory response with carbon monoxide in transplant-induced hepatic ischemia", reperfusion injury in rats, 2008, pp.48, 1608~1620
  51. Kitagawa T, "Protective effects of branched-chain amino acids on hepatic ischemia-reperfusion-induced liver injury in rats: a direct attenuation of Kupffer cell activation", Am J Physiol Gastrointest Liver Physiol, 304, pp.G346~G355 (2013)[DOI]
  52. Ellett JD, "Murine Kupffer cells are protective in total hepatic ischemia", reperfusion injury with bowel congestion through IL-10, 2010, pp.184, 5849~5858
  53. Sutter AG, "Intereukin-10 and Kupffer cells protect steatotic mice livers from ischemia-reperfusion injury", Eur Cytokine Netw, 25, pp.69~76 (2014)
  54. Yoshidome H, "Interleukin-10 suppresses hepatic ischemia", reperfusion injury in mice: implications of a central role for nuclear factor <TEX>${\kappa}B$<, Hepatology, pp.1999, 30[DOI]
  55. Si ZZ, "Recombinant adenovirus vector Ad-hIL-10 protects grafts from cold ischemia-reperfusion injury following orthotopic liver transplantation in rats", Hepatobiliary Pancreat Dis Int, 9, pp.144~148 (2010)
  56. Ke B, "Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity", Hum Gene Ther, 18, pp.355~366 (2007)[DOI]
  57. Gomez-Hurtado I, "Interleukin-10-mediated heme oxygenase 1-induced underlying mechanism in inflammatory down-regulation by norfloxacin in cirrhosis", Hepatology, 53, pp.935~944 (2011)[DOI]
  58. Devey L, "Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism", Mol Ther, 17, pp.65~72 (2009)[DOI]
  59. Shen XD, "Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia", reperfusion injury, 2011, pp.17, 201~210
  60. Ke B, "Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury", Mol Ther, 18, pp.1019~1025 (2010)[DOI]
  61. Kensler TW, "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway", Annu Rev Pharmacol Toxicol, 47, pp.89~116 (2007)[DOI]
  62. Loboda A, "Role of Nrf2", HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism, 2016, pp.73, 3221~3247
  63. Biswas C, "Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses", J Biol Chem, 289, pp.26882~26894 (2014)[DOI]
  64. Mylroie H, "<TEX>$PKC{\varepsilon}$<", TEX>-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosis, 2015, pp.106, 509~519
  65. Rao J, "ATF3-mediated NRF2", HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia, Am J Transplant, pp.2015, 15[DOI]
  66. Cursio R, "Autophagy and liver ischemia-reperfusion injury", BioMed Res Int, 2015, pp.417590~ (2015)
  67. Lee SC, "Activation of autophagy by everolimus confers hepatoprotection against ischemia-reperfusion injury", Am J Transplant, 16, pp.2042~2054 (2016)[DOI]
  68. Yun N, "Impaired autophagy contributes to hepatocellular damage during ischemia", reperfusion: heme oxygenase-1 as a possible regulator, 2014, pp.68, 168~177
  69. Xu D, "The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2", HO-1 pathway enhanced autophagy, 2017, pp.8, e2983~
  70. Caldwell CC, "Divergent functions of <TEX>$CD4^{+}$<", TEX> T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion, 2005, pp.289, G969~G976
  71. Uchida Y, "The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse", Hepatology, 51, pp.1363~1372 (2010)[DOI]
  72. Ji H, "Programmed death-1", B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury, 2010, pp.52, 1380~1389
  73. Uchida Y, "T-cell immunoglobulin mucin-3 determines severity of liver ischemia", reperfusion injury in mice in a TLR4-dependent manner, 2010, pp.139, 2195~2206
  74. Ji H, "T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury", Hepatology, 60, pp.2052~2064 (2014)[DOI]
  75. Zhang M, "Roles of dendritic cells in murine hepatic warm and liver transplantation-induced cold ischemia", reperfusion injury, 2013, pp.57, 1585~1596
  76. Bamboat ZM, "Conventional DCs reduce liver ischemia", reperfusion injury in mice via IL-10 secretion, 2010, pp.120, 559~569
  77. Arrenberg P, "Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice", Gastroenterology, 140, pp.646~655 (2011)[DOI]
  78. Beldi G, "Deletion of CD39 on natural killer cells attenuates hepatic ischemia", reperfusion injury in mice, 2010, pp.51, 1702~1711
  79. Kimura S, "Contribution of alloantigens to hepatic ischemia", reperfusion injury: roles of natural killer cells and innate immune recognition of nonself, 2016, pp.22, 80~90
  80. Qiao YL, "Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor kappa B activation in Kupffer cells", J Surg Res, 187, pp.653~659 (2014)[DOI]
  81. Sakai N, "Receptor activator of nuclear factor-<TEX>${\kappa}B$<", TEX> ligand (RANKL) protects against hepatic ischemia, Hepatology, pp.2012, 55[DOI]
  82. Li JD, "Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury", Transplant Proc, 42, pp.1582~1586 (2010)[DOI]
  83. Giakoustidis DE, "Attenuation of liver ischemia", reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression, 2010, pp.159, 720~728
  84. Kuboki S, "The peptidyl-prolyl isomerase, Pin1, facilitates <TEX>$NF-{\kappa}B$<", TEX> binding in hepatocytes and protects against hepatic ischemia, J Hepatol, pp.2009, 51[DOI]
  85. Li X, "Pre-conditioning with tanshinone IIA attenuates the ischemia", reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells, 2017, pp.89, 1392~1400
  86. Ogiku M, "Glycyrrhizin prevents liver injury by inhibition of high-mobility group box 1 production by Kupffer cells after ischemia-reperfusion in rats", J Pharmacol Exp Ther, 339, pp.93~98 (2011)[DOI]
  87. Venkatachalam AB, "Delivery of soluble heme oxygenase 1 cell-penetrating peptide into liver cells in in vitro and ex vivo models of cold ischemia", Eur Surg Res, 58, pp.51~68 (2017)[DOI]
  88. Yingli Xie, "Macrophage-targeting Fasudil treatment protects liver from the ischemia", reperfusion injury by promoting M2 macrophage polarization, 2018, BSR20171734~[DOI]
  89. Linares I, "PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model", PLoS One, 13, pp.e0195212~ (2018)[DOI]
  90. Guan LY, "Mechanisms of hepatic ischemia-reperfusion injury and protective effects of nitric oxide", World J Gastrointest Surg, 6, pp.122~128 (2014)[DOI]
  91. Yu HC, "Notch signal protects non-parenchymal cells from ischemia", reperfusion injury in vitro by repressing ROS, 2013, pp.12, 815~821
  92. Li Y, "MicroRNA-155 deficiency in Kupffer cells ameliorates liver ischemia-reperfusion injury in mice", Transplantation, 101, pp.1600~1608 (2017)[DOI]

관련 논문AI추천

Hepatic ischemia-reperfusion injury with respect to oxidative stress and inflammatory response: a narrative review임동건, Eun Kyung Choi영남대학교 의과대학 · Journal of Yeungnam Medical Science2023 · 제40권 제2호Roles of heterogenous hepatic macrophages in the progression of liver diseases한용현, Kyeong-Jin Lee, Mi-Yeon Kim생화학분자생물학회 · BMB Reports2022 · 제55권 제4호Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia- reperfusion injuryJia Liu, Ranyi Luo, Xiaojiaoyang Li, Yinhao Zhang대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Ischemia-free liver transplantation improves the prognosis of recipients using functionally marginal liver graftsDongping Wang, Maogen Chen, Min Zhang, Qiang Zhao, Shuai Wang, Weiqiang Ju, Xiaohong Lin, Xiaoshun He, Yichen Liang, Yiwen Guo, Yunhua Tang, Yuqi Dong, Zhiyong Guo, Zhonghao Xie대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제3호Comparison of the protective effects of infliximab and splenectomy on hepatic ischemia-reperfusion injury in rats: an experimental study이덕희, 임동건, 최은경, Jang Youngjun, Jung Hoon, Kwak Kyung-Hwa, Lee Shiback영남대학교 의과대학 · Journal of Yeungnam Medical Science2025 · 제42권 CD300E+ macrophages facilitate liver regeneration after splenectomy in decompensated cirrhotic patientsCheng Kun, Chen Xiao, Chen Yong, Duan Chujun, Liang Qingshan, Liu Hui, Ma Jingchang, Wang Dong, Yang Tao, Yin Jikai, Zhang Yuan, Zhuang Ran생화학분자생물학회 · Experimental and Molecular Medicine2025 · 제57권

이 간행물의 다른 논문 (6건)